Top

Published in:

01-06-2018

Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer

Authors: Tomoyuki Uchihara, Naoya Yoshida, Yoshifumi Baba, Taisuke Yagi, Tasuku Toihata, Eri Oda, Daisuke Kuroda, Tsugio Eto, Mayuko Ohuchi, Kenichi Nakamura, Hiroshi Sawayama, Koichi Kinoshita, Masaaki Iwatsuki, Takatsugu Ishimoto, Yasuo Sakamoto, Hideo Baba

Published in: Surgical Endoscopy | Issue 6/2018

Abstract

Background

Pulmonary morbidities after esophagectomy are still common and are a major cause of surgery-related mortality. The relationship between minimally invasive esophagectomy (MIE) and pulmonary morbidities is not clear. The current study aimed to examine the incidence of pulmonary morbidities after MIE and to clarify the associated risk factors.

Methods

Between May 2011 and December 2016, 184 patients underwent MIE for esophageal cancer. Clinical data were prospectively collected and analyzed. Patient- and surgery-related factors, relating to pulmonary complications, were compared between the complicated and uncomplicated cases.

Results

The incidence of any pulmonary morbidity following MIE was 17.9%. Univariate analysis showed that past heavy smoking [Brinkman index (BI) ≥ 1000], presence of neoadjuvant therapy, advanced clinical stage (stage III, IV), and intraoperative bleeding ≥ 600 g were candidates for being postoperative pulmonary morbidity risk factors. Multivariate analysis suggested that BI ≥ 1000 and advanced clinical stage were independent risk factors for causing pulmonary morbidities.

Conclusions

Past heavy smoking and advanced stage are independent risk factors for pulmonary morbidities after MIE. When performing MIE for such cases, various preoperative precautions and careful postoperative monitoring are necessary.

Available only for authorised users

Maas KW, Biere SS, van Hoogstraten IM, van der Peet DL, Cuesta MA (2014) Immunological changes after minimally invasive or conventional esophageal resection for cancer: a randomized trial. World J Surg 38(1):131–137. https://doi.org/10.1007/s00268-013-2233-0 CrossRefPubMed

Masuda M, Okumura M, Doki Y, Endo S, Hirata Y, Kobayashi J, Kuwano H, Motomura N, Nishida H, Saiki Y, Saito A, Shimizu H, Tanaka F, Tanemoto K, Toh Y, Tsukihara H, Wakui S, Yokomise H (2016) Thoracic and cardiovascular surgery in Japan during 2014: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 64(11):665–697. https://doi.org/10.1007/s11748-016-0695-3 CrossRefPubMedPubMedCentral

Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Sugihara K, Mori M (2014) A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 260(2):259–266. https://doi.org/10.1097/sla.0000000000000644 CrossRefPubMed

Mamidanna R, Bottle A, Aylin P, Faiz O, Hanna GB (2012) Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 255(2):197–203. https://doi.org/10.1097/SLA.0b013e31823e39fa CrossRefPubMed

Kataoka K, Takeuchi H, Mizusawa J, Ando M, Tsubosa Y, Koyanagi K, Daiko H, Matsuda S, Nakamura K, Kato K, Kitagawa Y (2016) A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409. Jpn J Clin Oncol 46(2):174–177. https://doi.org/10.1093/jjco/hyv178 CrossRefPubMed

Mu J, Gao S, Mao Y, Xue Q, Yuan Z, Li N, Su K, Yang K, Lv F, Qiu B, Liu D, Chen K, Li H, Yan T, Han Y, Du M, Xu R, Wen Z, Wang W, Shi M, Xu Q, Xu S, He J (2015) Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial. BMJ Open 5(11):e008328. https://doi.org/10.1136/bmjopen-2015-008328 CrossRefPubMedPubMedCentral

Briez N, Piessen G, Bonnetain F, Brigand C, Carrere N, Collet D, Doddoli C, Flamein R, Mabrut JY, Meunier B, Msika S, Perniceni T, Peschaud F, Prudhomme M, Triboulet JP, Mariette C (2011) Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer 11:310. https://doi.org/10.1186/1471-2407-11-310 CrossRefPubMedPubMedCentral

Zingg U, Smithers BM, Gotley DC, Smith G, Aly A, Clough A, Esterman AJ, Jamieson GG, Watson DI (2011) Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol 18(5):1460–1468. https://doi.org/10.1245/s10434-010-1474-5 CrossRefPubMed

Baba Y, Yoshida N, Shigaki H, Iwatsuki M, Miyamoto Y, Sakamoto Y, Watanabe M, Baba H (2016) Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg Oncol 264(2):305–311. https://doi.org/10.1097/sla.0000000000001510 CrossRef

10.

Saeki H, Tsutsumi S, Tajiri H, Yukaya T, Tsutsumi R, Nishimura S, Nakaji Y, Kudou K, Akiyama S, Kasagi Y, Nakanishi R, Nakashima Y, Sugiyama M, Ohgaki K, Sonoda H, Oki E, Maehara Y (2017) Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg 265(3):527–533. https://doi.org/10.1097/sla.0000000000001692 CrossRefPubMed

11.

Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York

12.

Shiozaki A, Fujiwara H, Okamura H, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Okamoto K, Ochiai T, Kokuba Y, Otsuji E (2012) Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett 3(4):907–912. https://doi.org/10.3892/ol.2012.589 PubMedPubMedCentralCrossRef

13.

Yoshida N, Watanabe M, Baba Y, Ishimoto T, Iwagami S, Sakamoto Y, Miyamoto Y, Karashima R, Baba H (2014) Influence of preoperative docetaxel, cisplatin, and 5-fluorouracil on the incidence of complications after esophagectomy for resectable advanced esophageal cancer. Dis Esophagus 27(4):374–379. https://doi.org/10.1111/dote.12117 CrossRefPubMed

14.

Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus april 2012 edited by the Japan Esophageal Society. Esophagus 12:1–30. https://doi.org/10.1007/s10388-014-0465-1 CrossRefPubMed

15.

National Cancer Institute (2010) Common terminology criteria for adverse events (CTCAE). United States Department of Health and Human Services, Bethesda

16.

Wilhelm F, Simon E, Boger C, Behrens HM, Kruger S, Rocken C (2017) Novel insights into gastric cancer: methylation of R-spondins and regulation of LGR5 by SP1. Mol Cancer Res 15(6):776–785. https://doi.org/10.1158/1541-7786.MCR-16-0472 CrossRefPubMed

17.

Paul DJ, Jamieson GG, Watson DI, Devitt PG, Game PA (2011) Perioperative risk analysis for acute respiratory distress syndrome after elective oesophagectomy. ANZ J Surg 81(10):700–706CrossRefPubMed

18.

Ferguson MK, Celauro AD, Prachand V (2011) Prediction of major pulmonary complications after esophagectomy. Ann Thoracic Surg 91(5):1494–1500. https://doi.org/10.1016/j.athoracsur.2010.12.036 (discussion 1500–1491)CrossRef

19.

Schieman C, Wigle DA, Deschamps C, Nichols Iii FC, Cassivi SD, Shen KR, Allen MS (2012) Patterns of operative mortality following esophagectomy. Dis Esophagus 25(7):645–651. https://doi.org/10.1111/j.1442-2050.2011.01304.x CrossRefPubMed

20.

Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K, Maehara Y (2011) In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol 18(6):1757–1765. https://doi.org/10.1245/s10434-010-1502-5 CrossRefPubMed

21.

Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379(9829):1887–1892. https://doi.org/10.1016/s0140-6736(12)60516-9 CrossRefPubMed

22.

Yibulayin W, Abulizi S, Lv H, Sun W (2016) Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis. World J Surg Oncol 14(1):304. https://doi.org/10.1186/s12957-016-1062-7 CrossRefPubMedPubMedCentral

23.

Zhou C, Zhang L, Wang H, Ma X, Shi B, Chen W, He J, Wang K, Liu P, Ren Y (2015) Superiority of minimally invasive oesophagectomy in reducing in-hospital mortality of patients with resectable oesophageal cancer: a meta-analysis. PLoS ONE 10(7):e0132889. https://doi.org/10.1371/journal.pone.0132889 CrossRefPubMedPubMedCentral

24.

Briez N, Piessen G, Torres F, Lebuffe G, Triboulet JP, Mariette C (2012) Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg 99(11):1547–1553. https://doi.org/10.1002/bjs.8931 CrossRefPubMed

25.

Petri R, Zuccolo M, Brizzolari M, Rossit L, Rosignoli A, Durastante V, Petrin G, De Cecchis L, Sorrentino M (2012) Minimally invasive esophagectomy: thoracoscopic esophageal mobilization for esophageal cancer with the patient in prone position. Surg Endosc 26(4):1102–1107. https://doi.org/10.1007/s00464-011-2006-5 CrossRefPubMed

26.

Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Ozaki N, Baba H (2014) Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today 44(3):526–532. https://doi.org/10.1007/s00595-013-0577-6 CrossRefPubMed

27.

Owen RM, Perez SD, Lytle N, Patel A, Davis SS, Lin E, Sweeney JF (2013) Impact of operative duration on postoperative pulmonary complications in laparoscopic versus open colectomy. Surg Endosc 27(10):3555–3563. https://doi.org/10.1007/s00464-013-2949-9 CrossRefPubMed

28.

Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP (2010) Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005–2008. J Gastrointest Surg 14(10):1492–1501. https://doi.org/10.1007/s11605-010-1328-2 CrossRefPubMed

29.

Yoshida N, Baba Y, Hiyoshi Y, Shigaki H, Kurashige J, Sakamoto Y, Miyamoto Y, Iwatsuki M, Ishimoto T, Kosumi K, Sugihara H, Harada K, Tokunaga R, Izumi D, Watanabe M, Baba H (2016) Duration of smoking cessation and postoperative morbidity after esophagectomy for esophageal cancer: how long should patients stop smoking before surgery? World J Surg 40(1):142–147. https://doi.org/10.1007/s00268-015-3236-9 CrossRefPubMed

30.

Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Kurashige J, Sakamoto Y, Miyamoto Y, Ishimoto T, Kosumi K, Tokunaga R, Imamura Y, Ida S, Hiyoshi Y, Watanabe M, Baba H (2016) Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg 40(8):1910–1917. https://doi.org/10.1007/s00268-016-3549-3 CrossRefPubMed

31.

Filip B, Scarpa M, Cavallin F, Cagol M, Alfieri R, Saadeh L, Ancona E, Castoro C (2015) Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol 41(6):787–794. https://doi.org/10.1016/j.ejso.2015.02.014 CrossRefPubMed

32.

Mantziari S, Hubner M, Demartines N, Schafer M (2014) Impact of preoperative risk factors on morbidity after esophagectomy: is there room for improvement? World J Surg 38(11):2882–2890. https://doi.org/10.1007/s00268-014-2686-9 CrossRefPubMed

33.

Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K (2002) Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 28(4):396–400CrossRefPubMed

34.

Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, Katsuda M, Tsuji T, Nakatani Y, Yamaue H (2008) An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbeck’s Arch Surg 393(2):127–133. https://doi.org/10.1007/s00423-007-0253-7 CrossRef

35.

Agrelli TF, de Carvalho Ramos M, Guglielminetti R, Silva AA, Crema E (2012) Preoperative ambulatory inspiratory muscle training in patients undergoing esophagectomy. A pilot study. Int Surg 97(3):198–202. https://doi.org/10.9738/cc136.1 CrossRefPubMedPubMedCentral

36.

Inoue J, Ono R, Makiura D, Kashiwa-Motoyama M, Miura Y, Usami M, Nakamura T, Imanishi T, Kuroda D (2013) Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus 26(1):68–74. https://doi.org/10.1111/j.1442-2050.2012.01336.x CrossRefPubMed

37.

Yamana I, Takeno S, Hashimoto T, Maki K, Shibata R, Shiwaku H, Shimaoka H, Shiota E, Yamashita Y (2015) Randomized controlled study to evaluate the efficacy of a preoperative respiratory rehabilitation program to prevent postoperative pulmonary complications after esophagectomy. Dig Surg 32(5):331–337. https://doi.org/10.1159/000434758 CrossRefPubMed

38.

Akutsu Y, Matsubara H, Shuto K, Shiratori T, Uesato M, Miyazawa Y, Hoshino I, Murakami K, Usui A, Kano M, Miyauchi H (2010) Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery 147(4):497–502. https://doi.org/10.1016/j.surg.2009.10.048 CrossRefPubMed

39.

Engelman E, Maeyens C (2010) Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy. J Gastrointest Surg 14(5):788–804. https://doi.org/10.1007/s11605-010-1168-0 CrossRefPubMed

40.

Park SY, Lee HS, Jang HJ, Joo J, Zo JI (2012) Efficacy of intraoperative, single-bolus corticosteroid administration to prevent postoperative acute respiratory failure after oesophageal cancer surgery. Interact Cardiovasc Thorac Surg 15(4):639–643. https://doi.org/10.1093/icvts/ivs167 CrossRefPubMedPubMedCentral

41.

Gao Q, Mok HP, Wang WP, Xiao F, Chen LQ (2014) Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: a meta-analysis. Oncol Lett 7(2):349–356. https://doi.org/10.3892/ol.2013.1748 CrossRefPubMed

42.

Kawahara Y, Ninomiya I, Fujimura T, Funaki H, Nakagawara H, Takamura H, Oyama K, Tajima H, Fushida S, Inaba H, Kayahara M (2010) Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus 23(4):329–339. https://doi.org/10.1111/j.1442-2050.2009.01010.x CrossRefPubMed

43.

Makino H, Kunisaki C, Kosaka T, Akiyama H, Morita S, Endo I (2011) Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer. Brit J Surg 98(7):975–982. https://doi.org/10.1002/bjs.7499 CrossRefPubMed

44.

Nagai Y, Watanabe M, Baba Y, Iwatsuki M, Hirashima K, Karashima R, Kurashige J, Kinoshita K, Baba H (2013) Preventive effect of sivelestat on postoperative respiratory disorders after thoracic esophagectomy. Surg Today 43(4):361–366. https://doi.org/10.1007/s00595-013-0508-6 CrossRefPubMed

45.

Nishiyama J, Matsuda M, Ando S, Hirasawa M, Suzuki T, Makuuchi H (2012) The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer. Surg Today 42(7):659–665. https://doi.org/10.1007/s00595-011-0105-5 CrossRefPubMed

46.

Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M (2007) Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus 20(6):478–486. https://doi.org/10.1111/j.1442-2050.2007.00699.x CrossRefPubMed

Title: Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer
Authors: Tomoyuki Uchihara
Naoya Yoshida
Yoshifumi Baba
Taisuke Yagi
Tasuku Toihata
Eri Oda
Daisuke Kuroda
Tsugio Eto
Mayuko Ohuchi
Kenichi Nakamura
Hiroshi Sawayama
Koichi Kinoshita
Masaaki Iwatsuki
Takatsugu Ishimoto
Yasuo Sakamoto
Hideo Baba
Publication date: 01-06-2018
Publisher: Springer US
Published in: Surgical Endoscopy / Issue 6/2018
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-017-5993-z

ACC 2024 Congress

Springer Medicine

Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

Laparoscopic common bile duct exploration

Intra-corporeal hand-sewn esophagojejunostomy is a safe and feasible procedure for totally laparoscopic total gastrectomy: short-term outcomes in 100 consecutive patients

Influence of antrum size on gastric emptying and weight-loss outcomes after laparoscopic sleeve gastrectomy (preliminary analysis of a randomized trial)

Comparison of ENDO CUT mode and FORCED COAG mode for the formation of stricture after esophageal endoscopic submucosal dissection in an in vivo porcine model

SAGES Foregut Surgery Masters Program: a surgeon’s social media resource for collaboration, education, and professional development

Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes